Correlation Between Cizzle Biotechnology and Sabre Insurance

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cizzle Biotechnology and Sabre Insurance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cizzle Biotechnology and Sabre Insurance into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cizzle Biotechnology Holdings and Sabre Insurance Group, you can compare the effects of market volatilities on Cizzle Biotechnology and Sabre Insurance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cizzle Biotechnology with a short position of Sabre Insurance. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cizzle Biotechnology and Sabre Insurance.

Diversification Opportunities for Cizzle Biotechnology and Sabre Insurance

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between Cizzle and Sabre is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Cizzle Biotechnology Holdings and Sabre Insurance Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sabre Insurance Group and Cizzle Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cizzle Biotechnology Holdings are associated (or correlated) with Sabre Insurance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sabre Insurance Group has no effect on the direction of Cizzle Biotechnology i.e., Cizzle Biotechnology and Sabre Insurance go up and down completely randomly.

Pair Corralation between Cizzle Biotechnology and Sabre Insurance

Assuming the 90 days trading horizon Cizzle Biotechnology Holdings is expected to generate 2.3 times more return on investment than Sabre Insurance. However, Cizzle Biotechnology is 2.3 times more volatile than Sabre Insurance Group. It trades about 0.08 of its potential returns per unit of risk. Sabre Insurance Group is currently generating about -0.12 per unit of risk. If you would invest  155.00  in Cizzle Biotechnology Holdings on September 3, 2024 and sell it today you would earn a total of  25.00  from holding Cizzle Biotechnology Holdings or generate 16.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Cizzle Biotechnology Holdings  vs.  Sabre Insurance Group

 Performance 
       Timeline  
Cizzle Biotechnology 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Cizzle Biotechnology Holdings are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Cizzle Biotechnology exhibited solid returns over the last few months and may actually be approaching a breakup point.
Sabre Insurance Group 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sabre Insurance Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Cizzle Biotechnology and Sabre Insurance Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cizzle Biotechnology and Sabre Insurance

The main advantage of trading using opposite Cizzle Biotechnology and Sabre Insurance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cizzle Biotechnology position performs unexpectedly, Sabre Insurance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sabre Insurance will offset losses from the drop in Sabre Insurance's long position.
The idea behind Cizzle Biotechnology Holdings and Sabre Insurance Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency